Discover
PRAX
Praxis Precision Medicines, Inc.
259.86
1 x 281.28
1 x 296.86
bid
ask
-
3.69
1.40%
1 @ 04:00 PM
259.86 +0.00 (0.00%)
| Ytd | -11.83% | |
| 1y | 374.54% |
259.00
day range
267.56
52.34
52 week range
386.33
| Open | 266.91 | Prev Close | 263.55 | Low | 259.00 | High | 267.56 | Mkt Cap | 7.26B |
| Vol | 517.23K | Avg Vol | 408.88K | EPS | -12.95 | P/E | N/A | Forward P/E | -27.85 |
| Beta | 2.81 | Short Ratio | 11.90 | Inst. Own | 123.39% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-09 | 50-d Avg | 330.61 | 200-d Avg | 316.79 | 1yr Est | 644.42 |
| Income Statement | |||
| Operating Expenses | 96.90M | ||
| Research and Development Expense | 69.42M | ||
| Selling, General and Administrative Expense | 27.49M | ||
| Operating Income | -96.90M | ||
| Net Income | -83.72M | ||
| Net Income Common Stock | -83.72M | ||
| Net Income Common Stock (USD) | -83.72M | ||
| Consolidated Income | -83.72M | ||
| Earnings per Basic Share | -2.87 | ||
| Earnings per Basic Share (USD) | -2.87 | ||
| Earnings per Diluted Share | -2.87 | ||
| Earning Before Interest & Taxes (EBIT) | -83.72M | ||
| Earning Before Interest & Taxes (USD) | -83.72M | ||
| Weighted Average Shares | 29.13M | ||
| Weighted Average Shares Diluted | 29.13M | ||
| Balance Sheet | |||
| Cash and Equivalents | 474.76M | ||
| Cash and Equivalents (USD) | 474.76M | ||
| Investments | 899.08M | ||
| Investments Current | 283.79M | ||
| Investments Non-Current | 615.29M | ||
| Current Assets | 771.90M | ||
| Property, Plant & Equipment Net | 1.49M | ||
| Total Assets | 1.39B | ||
| Debt Current | 1.09M | ||
| Total Debt | 1.09M | ||
| Current Liabilities | 49.06M | ||
| Total Liabilities | 49.06M | ||
| Accumulated Retained Earnings (Deficit) | -1.32B | ||
| Accumulated Other Comprehensive Income | -2.67M | ||
| Shareholders Equity | 1.34B | ||
| Shareholders Equity (USD) | 1.34B | ||
| Assets Non-Current | 618.20M | ||
| Total Debt (USD) | 1.09M | ||
| Goodwill and Intangible Assets | 773.00K | ||
| Trade and Non-Trade Payables | 23.39M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 352.00K | ||
| Net Cash Flow from Financing | 4.57M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -61.99M | ||
| Capital Expenditure | -1.02M | ||
| Issuance (Purchase) of Equity Shares | 4.88M | ||
| Net Cash Flow from Investing | 10.98M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 12.00M | ||
| Net Cash Flow from Operations | -77.54M | ||
| Share Based Compensation | 11.31M | ||